Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2012

01-06-2012 | Original Article

Loss of Expression of DNA Mismatch Repair Proteins in Aberrant Crypt Foci Identified In Vivo by Magnifying Colonoscopy in Subjects with Hereditary Nonpolyposic and Sporadic Colon Rectal Cancer

Authors: Miguel Angel Ramírez-Ramírez, Sergio Sobrino-Cossío, José Guillermo de la Mora-Levy, Angélica Hernández-Guerrero, Verónica de Jesús Macedo-Reyes, Héctor Aquiles Maldonado-Martínez, Juan Octavio Alonso-Larraga, Mauro Eduardo Ramírez-Solis

Published in: Journal of Gastrointestinal Cancer | Issue 2/2012

Login to get access

Abstract

Purpose

The aims of this study are to characterize the frequency, density, and distribution of aberrant crypt foci (ACF) and its histological features and to determine the frequency of loss of expression of DNA mismatch repair (MMR) proteins of subjects with hereditary nonpolyposic colorectal cancer (HNPCC) and sporadic colon rectal cancer (CRC).

Methods

Patients with HNPCC, first-degree relatives of subjects with HNPCC, sporadic CRC, and average risk subjects of sporadic CRC were included prospectively. Total colonoscopy with chromoendoscopy using methylene blue 0.5% and magnification in the right colon (cecum and 20 cm of the ascending colon) and in the left colon (rectum) was performed; loss of expression of MLH1 and MSH2 was evaluated by immunohistochemistry in confirmed ACF.

Results

Fifty-two subjects were included. Thirty-eight of the 119 ACF detected by endoscopy were biopsied. In 14 of the 38 specimens (36.8%), ACF were confirmed by histology (Cohen's kappa, 0.44). In subjects with HNPCC, ACF were identified more frequently in the right segment of the colon than in the left (73.1% vs. 26%); in contrast, ACF predominated in the left segment of the colon (89.3% vs. 10.6%) in subjects with sporadic CRC. There was a loss of MLH1 expression in ACF in subjects with HNPCC.

Conclusions

In HNPCC, we found a greater density of ACF in the right colon, and in sporadic CRC, greater density in the left. ACF present loss in the expression of DNA MMR protein and can be used as an early marker in patients with a risk of HNPCC in whom carcinogenesis appears to be accelerated.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
3.
go back to reference DeFrancisco J, Grady WM. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc. 2003;58:390–408.PubMedCrossRef DeFrancisco J, Grady WM. Diagnosis and management of hereditary non-polyposis colon cancer. Gastrointest Endosc. 2003;58:390–408.PubMedCrossRef
4.
go back to reference Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 2001;121:198–213.PubMedCrossRef Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 2001;121:198–213.PubMedCrossRef
5.
go back to reference Lubinski J, Lynch HT, Lynch J, et al. HNPCC (Lynch syndrome): differential diagnosis, molecular genetics and management—a review. Hered Cancer Clin Prac. 2003;1:7–18.CrossRef Lubinski J, Lynch HT, Lynch J, et al. HNPCC (Lynch syndrome): differential diagnosis, molecular genetics and management—a review. Hered Cancer Clin Prac. 2003;1:7–18.CrossRef
6.
go back to reference Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996;2:169–74.PubMedCrossRef Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996;2:169–74.PubMedCrossRef
7.
go back to reference Boland CR, Koi M, Chang DK, et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer. 2008;7:41–52.PubMedCrossRef Boland CR, Koi M, Chang DK, et al. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside. Fam Cancer. 2008;7:41–52.PubMedCrossRef
8.
go back to reference Piñol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986–94.PubMedCrossRef Piñol V, Castells A, Andreu M, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293:1986–94.PubMedCrossRef
9.
go back to reference Müller A, Giuffre G, Edmonston TB, et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mo Diagn. 2004;6:308–15.CrossRef Müller A, Giuffre G, Edmonston TB, et al. Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mo Diagn. 2004;6:308–15.CrossRef
10.
go back to reference Overbeek LI, Ligtenberg MJ, Willems RW, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008;32:1246–51.PubMedCrossRef Overbeek LI, Ligtenberg MJ, Willems RW, et al. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008;32:1246–51.PubMedCrossRef
11.
go back to reference Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535–49.PubMed Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535–49.PubMed
12.
go back to reference Church J. Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol. 1998;93:2289–90.PubMedCrossRef Church J. Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol. 1998;93:2289–90.PubMedCrossRef
14.
go back to reference Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1997–81.CrossRef Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1997–81.CrossRef
15.
go back to reference Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–5.PubMedCrossRef Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001;48:812–5.PubMedCrossRef
16.
go back to reference Davila RE, Rajan E, Baron TH, et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546–57.PubMedCrossRef Davila RE, Rajan E, Baron TH, et al. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc. 2006;63:546–57.PubMedCrossRef
17.
go back to reference Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary finding. Cancer Lett. 1987;37:147–51.PubMedCrossRef Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary finding. Cancer Lett. 1987;37:147–51.PubMedCrossRef
18.
go back to reference Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplasic foci in human colonic mucosa. Cancer Res. 1991;51:1564–7.PubMed Pretlow TP, Barrow BJ, Ashton WS, et al. Aberrant crypts: putative preneoplasic foci in human colonic mucosa. Cancer Res. 1991;51:1564–7.PubMed
19.
go back to reference Roncucci L, Pedroni M, Vaccina F, et al. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1–18.PubMedCrossRef Roncucci L, Pedroni M, Vaccina F, et al. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif. 2000;33:1–18.PubMedCrossRef
20.
go back to reference Alrawi SJ, Schiff M, Carroll RE, et al. Aberrant crypt foci. Anticancer Res. 2006;26:107–19.PubMed Alrawi SJ, Schiff M, Carroll RE, et al. Aberrant crypt foci. Anticancer Res. 2006;26:107–19.PubMed
21.
go back to reference Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9:2642–9.PubMed Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol. 2003;9:2642–9.PubMed
22.
go back to reference Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis. J Gastroenterol Hepatol. 2005;20:173–81.PubMedCrossRef Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis. J Gastroenterol Hepatol. 2005;20:173–81.PubMedCrossRef
23.
go back to reference Yamashita N, Minamoto T, Ochiai A, et al. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: is there preference among K-ras mutants for malignant progression? Cancer. 1995;75:1527–33.PubMedCrossRef Yamashita N, Minamoto T, Ochiai A, et al. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: is there preference among K-ras mutants for malignant progression? Cancer. 1995;75:1527–33.PubMedCrossRef
24.
go back to reference Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res. 2001;61:896–9.PubMed Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res. 2001;61:896–9.PubMed
25.
go back to reference Nucci MR, Robinson CR, Longo P, et al. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol. 1997;28:1396–407.PubMedCrossRef Nucci MR, Robinson CR, Longo P, et al. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol. 1997;28:1396–407.PubMedCrossRef
26.
go back to reference Di Gregorio C, Losi L, Fante R, et al. Histology of aberrant crypt foci in the human colon. Histopathology. 1997;30:328–34.PubMedCrossRef Di Gregorio C, Losi L, Fante R, et al. Histology of aberrant crypt foci in the human colon. Histopathology. 1997;30:328–34.PubMedCrossRef
27.
go back to reference Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.PubMedCrossRef Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.PubMedCrossRef
28.
go back to reference Heinen CD, Shivapurkar N, Tang Z, et al. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 1996;56:5339–41.PubMed Heinen CD, Shivapurkar N, Tang Z, et al. Microsatellite instability in aberrant crypt foci from human colons. Cancer Res. 1996;56:5339–41.PubMed
29.
go back to reference Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657–62.PubMedCrossRef Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657–62.PubMedCrossRef
30.
go back to reference Mutch MG, Schoen RE, Fleshman JW, et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol. 2009;7:568–74.PubMedCrossRef Mutch MG, Schoen RE, Fleshman JW, et al. A multicenter study of prevalence and risk factors for aberrant crypt foci. Clin Gastroenterol Hepatol. 2009;7:568–74.PubMedCrossRef
Metadata
Title
Loss of Expression of DNA Mismatch Repair Proteins in Aberrant Crypt Foci Identified In Vivo by Magnifying Colonoscopy in Subjects with Hereditary Nonpolyposic and Sporadic Colon Rectal Cancer
Authors
Miguel Angel Ramírez-Ramírez
Sergio Sobrino-Cossío
José Guillermo de la Mora-Levy
Angélica Hernández-Guerrero
Verónica de Jesús Macedo-Reyes
Héctor Aquiles Maldonado-Martínez
Juan Octavio Alonso-Larraga
Mauro Eduardo Ramírez-Solis
Publication date
01-06-2012
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2012
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-011-9303-z

Other articles of this Issue 2/2012

Journal of Gastrointestinal Cancer 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.